Mediantechn
Research Mediantechn (ALMDT) on Bullrun: market cap EUR 220.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALMDT
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 220.66M
- Financial periodFY2025
- RevenueEUR 23.36M
- Revenue growth1.8%
- Net income-EUR 34.07M
- Free cash flow-EUR 18.17M
- Gross margin103.0%
Valuation Snapshot
latest market cap is EUR 220.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 23.36M | -EUR 34.07M | -EUR 18.17M | 103.0% | -0.93 | EUR 18.25M | EUR 21.76M | -EUR 35.15M |
| FY2024 | EUR 22.95M | -EUR 25.24M | -EUR 19.03M | 103.9% | -1.36 | EUR 8.13M | EUR 29.44M | -EUR 33.97M |
| FY2023 | EUR 22.23M | -EUR 22.98M | -EUR 21.53M | 104.5% | -1.25 | EUR 19.51M | EUR 19.96M | -EUR 10.29M |
| FY2022 | EUR 23.67M | -EUR 20.21M | -EUR 17.18M | 103.2% | -1.28 | EUR 21.47M | EUR 18.15M | -EUR 7.25M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 220.66M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Mediantechn
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Mediantechn's market cap?
Mediantechn's market capitalization is EUR 220.66M.
What does Mediantechn do?
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.